Madison Boles, MD
Internal Medicine · Jefferson City, TNNPI 1467071969
Payments from drug & device makers
Across 40 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$158
- GSK$141
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$95
- Pfizer$67
- E.r. Squibb & Sons, L.L.C.$66
- Boston Scientific$39
- plus $182 from 7 others
What the payments were for
- Food & beverage$748100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $158 |
| GSK | 7 | $141 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $95 |
| Pfizer | 4 | $67 |
| E.r. Squibb & Sons, L.L.C. | 4 | $66 |
| Boston Scientific | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Corcept Therapeutics | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Medtronic | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca | 1 | $14 |
How this compares
$748 in reported general payments places this provider in the 65th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 48 | $440 |
| Losartan Potassium | 24 | $286 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $257 |
| Gabapentin | 24 | $223 |
| Levothyroxine Sodium | 35 | $197 |
| Fluticasone Propionate | 20 | $161 |
| Hydroxyzine Hcl | 24 | $152 |
| Omeprazole | 30 | $142 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $139 |
| Rosuvastatin Calcium | 16 | $139 |
| Metformin Hcl ErMetformin Hcl | 26 | $122 |
| Escitalopram Oxalate | 15 | $111 |
| Amlodipine Besylate | 22 | $89 |
| Sertraline Hcl | 14 | $80 |
| Pantoprazole Sodium | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Jefferson City
- John KirbyJefferson City$1.2M
- Mark McKenzieChattanooga$11.9M
- Bernard GrunstraBristol$6.4M
- Jewel WhiteKingsport$5.7M
- Judith WhiteKingsport$5.6M
- Obadias MarquezOoltewah$2.8M
- Amanda Moore MillerKnoxville$2.3M
- Rick WhilesBristol$1.5M
- John AndersonNashville$1.5M
- David MorinKingsport$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.